Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connective tissue associated pulmonary arterial hypertension.

J G Coghlan1, C Handler

  • 1Department of Cardiology, Royal Free Hospital, London, UK. Gerry.Coghlan@royalfree.nhs.uk

Lupus
|April 26, 2006
PubMed
Summary

Pulmonary hypertension linked to connective tissue diseases is less common but has a worse prognosis than idiopathic pulmonary hypertension. Early diagnosis and disease-modifying therapies significantly improve outcomes for systemic sclerosis patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension.

Journal of scleroderma and related disorders·2022
Same author

Safety and feasibility audit of a home-based drug-transitioning approach for patients with pulmonary arterial hypertension: an observational study.

European journal of cardiovascular nursing·2018
Same author

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.

Arthritis & rheumatology (Hoboken, N.J.)·2015
Same author

UK resources in the care of adults with Down's syndrome.

BMJ (Clinical research ed.)·2014
Same author

Scleroderma and breast implants.

QJM : monthly journal of the Association of Physicians·2014
Same author

Cardiac arrest due to accidental hypothermia--a 20 year review of a rare condition in an urban area.

Resuscitation·2014

Area of Science:

  • Rheumatology
  • Cardiology
  • Pulmonology

Background:

  • Pulmonary hypertension (PH) understanding has grown, shifting its perception from rare and lethal to uncommon and treatable.
  • Progress in connective tissue disease-associated PH has lagged behind general PH research.
  • This review synthesizes key data on connective tissue disease-associated PH, incorporating proprietary pharmaceutical and institutional data.

Purpose of the Study:

  • To review influential data on connective tissue disease-associated pulmonary hypertension.
  • To provide insights from pharmaceutical company data and the Royal Free Hospital database.
  • To clarify the prevalence, natural history, and treatment impact on connective tissue disease-associated PH.

Main Methods:

  • Literature review of influential publications on connective tissue disease-associated PH.

Related Experiment Videos

  • Analysis of on-file data from pharmaceutical companies.
  • Examination of data from the Royal Free Hospital database.

    • Main Results:

    • The prevalence of PH associated with connective tissue diseases is lower than commonly believed.
    • The natural history and prognosis for systemic sclerosis-associated PH are poorer compared to idiopathic PH.
    • Timely administration of disease-modifying therapies significantly enhances prognosis for systemic sclerosis-associated PH.

    Conclusions:

    • Early identification of patients with connective tissue disease-associated PH is crucial for advancing research and treatment.
    • Analyzing disease progression drivers in early-stage connective tissue disease-associated PH is key to future progress.
    • Connective tissue disease-associated PH offers an opportunity for early diagnosis and academic rheumatology research.